Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Neth J Med ; 71(5): 253-6, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23799312

ABSTRACT

¹8F-fluorodeoxyglucose positron emission tomography (¹8FDG-PET) scintigraphy is a useful imaging technique in the evaluation of metastasised thyroid carcinoma. Administration of recombinant human thyrotropin (rhTSH, Thyrogen®) increases the diagnostic yield of this procedure. Here we present a 64-year-old male who was followed for Hürthle cell carcinoma of the thyroid with several intrapulmonary metastases. He developed sudden complaints of neck pain following rhTSH administration as part of the routine preparation for a diagnostic ¹8FDG-PET÷CT procedure. This investigation subsequently revealed a previously undetected metastatic lesion in the first cervical vertebra, with no signs of spinal cord compression. Treatment with a nonsteroidal anti-inflammatory drug reduced the symptoms sufficiently, and a few weeks later the neurosurgeon performed a complete resection of the metastasis. It is likely that the symptoms were caused by oedema and÷or increased blood flow to the lesion. Physicians should be aware that rhTSH administration to patients with disseminated thyroid carcinoma may lead to sudden onset of symptoms caused by previously occult metastases.


Subject(s)
Adenocarcinoma, Follicular/diagnostic imaging , Cervical Vertebrae/diagnostic imaging , Spinal Neoplasms/diagnostic imaging , Thyroid Neoplasms/diagnostic imaging , Thyrotropin Alfa/adverse effects , Adenocarcinoma, Follicular/secondary , Adenoma, Oxyphilic , Fluorodeoxyglucose F18 , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/secondary , Male , Middle Aged , Neck Pain/etiology , Positron-Emission Tomography , Radiopharmaceuticals , Spinal Neoplasms/complications , Spinal Neoplasms/secondary , Thyroid Neoplasms/pathology
3.
Eur J Surg Oncol ; 32(1): 108-12, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16303280

ABSTRACT

PURPOSE: To prospectively describe in a population of oncological second opinion patients: (1) the outcome of routine revisions of histopathological and radiological material, (2) the frequency and extent of discrepancy between the second and first opinion and (3) the location of further treatment or follow-up. PATIENTS AND METHODS: In a population of 466 consecutive patients seeking a second opinion at the Surgical Oncology Outpatient Clinic, demographic and clinical patient characteristics were registered prospectively, as were the results of routine revision of histopathological and radiological material and the location of further treatment or follow-up. A classification system was developed to categorize the differences between the second and first opinion. RESULTS: The mean age of the 403 eligible patients was 52 years. Most patients (87%) were women, of whom 83% were diagnosed with breast cancer. Revision of histopathological and radiological material was performed in 80 and 61% of the cases, respectively, and resulted in a major change in treatment or prognosis in 3 and 2% of patients, respectively. In 317 patients (79%), the second opinion could be compared with the first opinion, resulting in an identical advise in 68%, a minor discrepancy in 16% and a major discrepancy in another 16% of patients. For further treatment 78% of patients were referred back to their first specialist. CONCLUSION: One third of patient-initiated second opinion consultations resulted in a discrepancy with the first opinion. Half of these different advise lead to major changes in therapy or prognosis.


Subject(s)
Medical Oncology/classification , Neoplasms/surgery , Referral and Consultation/classification , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Patient Participation , Prognosis , Prospective Studies , Reproducibility of Results , Surveys and Questionnaires
4.
Ned Tijdschr Geneeskd ; 149(17): 924-8, 2005 Apr 23.
Article in Dutch | MEDLINE | ID: mdl-15884405

ABSTRACT

Members of the Dutch working group on soft tissue tumours developed an up-to-standard evidence-based multidisciplinary clinical practice guideline for the diagnosis of soft tissue tumours and the treatment and follow-up of soft tissue sarcomas, in cooperation with the Dutch Association of Comprehensive Cancer Centres and the Dutch Institute for Healthcare Improvement. A soft tissue sarcoma is defined as every non-epithelial tumour that does not originate in haematopoietic or lymphatic system, central nervous system or bone. The guideline lists 'alarm signals' to raise awareness of malignancy and recommends consulting a multidisciplinary team. Non-invasive imaging has to be completed before proceeding to any invasive (diagnostic) procedure or assessment of dissemination. Aspiration cytology can be useful for differentiating between sarcoma and other malignancies. A definite diagnosis is obtained by means of image-guided needle biopsy. Tumours will be classified according to the World Health Organization and graded according to the Federation Nationale des Centres de Lutte Contre le Cancer. Surgical excision with a tumour free margin of 2 cm is the core of therapy, taking into account vital structures when necessary. In case of small superficial tumours (diameter < or = 3 cm) excision biopsy may be justified. Radiotherapy is almost always necessary and certainly indicated when wide margins are impossible even after re-resection. In the case of primary metastatic disease, an individual decision should be taken after multi-disciplinary consultation concerning the possibility of curative or palliative treatment. Neither neo-adjuvant nor adjuvant chemotherapy is standard. Chemotherapy may be useful in metastatic disease. The guideline advises referring patients who are eligible for chemotherapy to a centre and that they should be included in a study protocol.


Subject(s)
Sarcoma/diagnosis , Sarcoma/therapy , Soft Tissue Neoplasms/diagnosis , Soft Tissue Neoplasms/therapy , Diagnosis, Differential , Humans , Lymphatic Metastasis/diagnosis , Netherlands , Sarcoma/pathology , Societies, Medical , Soft Tissue Neoplasms/pathology
5.
Colorectal Dis ; 6(6): 406-17, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15521928

ABSTRACT

Abstract The treatment options for primary irresectable rectal cancers are discussed. Assessment of tumour stage is the first step for an appropriate choice of treatment. Following a diagnosis of rectal cancer, a vast array of diagnostic procedures is available to determine its stage, and thereby its best treatment options. From the many (new) diagnostic options the merits and drawbacks are discussed. If a diagnosis of irresectability is made, further treatment options should include radiotherapy in most cases, some aspects of timing and application, i.e. intra-operative treatment are discussed. Chemotherapy options are manifold, the results are discussed and some new options are explored.


Subject(s)
Neoplasm Staging/methods , Rectal Neoplasms/diagnosis , Rectal Neoplasms/therapy , Biopsy, Needle , Chemotherapy, Adjuvant , Combined Modality Therapy , Endosonography/methods , Female , Humans , Immunohistochemistry , Laparoscopy/methods , Laparotomy/methods , Magnetic Resonance Imaging/methods , Male , Neoplasm Staging/mortality , Palpation/methods , Perioperative Care , Physical Examination , Positron-Emission Tomography/methods , Prognosis , Radiotherapy, Adjuvant , Rectal Neoplasms/mortality , Risk Assessment , Survival Analysis
6.
Acad Radiol ; 11(6): 649-60, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15172367

ABSTRACT

RATIONALE AND OBJECTIVES: To show the impact of the introduction of multi-detector computed tomography (CT) on radiologic workflow and to demonstrate how this reflects on picture archiving and communications systems (PACS) requirements. MATERIALS AND METHODS: Production measurements were obtained from different CT scanners (first two single-slice CT scanners; from December 2001 single and 4-slice CT; from April 2002 single and 16-slice CT) in number of patients from the radiologic information system. Implications on our PACS were recorded in terms of images and studies stored. Furthermore, our PACS design was made so that optimal use of 3-dimensional imaging within the radiologic workflow was possible. Finally, the number of non-diagnosed studies were recorded every day since the start of the transition to a filmless radiology department. RESULTS: This PACS design achieved a high level of integration between simple viewing and advanced 3-dimensional imaging and is optimized for handling large amounts of data. Overall increase of patients scanned with CT from January 2002-December 2003 was 54%. The number of series increased by 286% from December 2001-April 2003 and by 130% from April 2002-December 2003. From January 2002-February 2003, the number of images per patient increased from 175 to 450 (157%). Non-diagnosed studies decreased from about 100-120 before to practically zero after PACS implementation. CONCLUSION: PACS significantly increases productivity because of availability of the images and elimination of certain manual tasks. These results show that although the amount of examinations increases significantly with the introduction of MDCT, simultaneous introduction of PACS and filmless operation allows radiologists to handle the growth in workload.


Subject(s)
Imaging, Three-Dimensional/methods , Radiology Information Systems , Tomography, X-Ray Computed/methods , Efficiency , Humans , Imaging, Three-Dimensional/instrumentation , Radiology , Technology, Radiologic
7.
Thorax ; 59(7): 596-601, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15223868

ABSTRACT

BACKGROUND: Positron emission tomography (PET) is accurate for mediastinal staging of lung cancer but has a moderate positive predictive value, necessitating pathological verification. Endoscopic ultrasonography with fine needle aspiration (EUS-FNA) is a technique for tissue verification of mediastinal and upper retroperitoneal abnormalities. The use of EUS-FNA may decrease the number of surgical procedures and thereby staging costs. METHODS: EUS-FNA was used prospectively for the cytological assessment of mediastinal and/or upper retroperitoneal PET hot spots in patients with suspected lung cancer. Only if EUS-FNA was positive for malignancy was subsequent mediastinoscopy or exploratory thoracotomy cancelled. The cost effectiveness of EUS-FNA was determined. RESULTS: Of 488 consecutive patients with suspected lung cancer, 81 were enrolled with mediastinal and/or upper retroperitoneal PET hot spots. EUS-FNA was positive in 50 (62%) patients, negative in six, and inconclusive in 25. Of the 31 negative or inconclusive patients, 26 underwent surgical staging (resulting in 14 patients with and 12 without mediastinal malignancy), while five patients had mediastinal metastases during follow up. No EUS-FNA related morbidity or mortality was encountered. The accuracy of the decision to proceed to surgery (or not) on the basis of EUS-FNA was 77% (95% CI 68 to 86). EUS-FNA detected more mediastinal abnormalities than PET except for the upper mediastinal region. Addition of EUS-FNA to conventional lung cancer staging reduced staging costs by 40% per patient, mainly due to a decrease in surgical staging procedures. CONCLUSION: EUS-FNA can replace more than half of the surgical staging procedures in lung cancer patients with mediastinal and/or upper retroperitoneal PET hot spots, thereby saving 40% of staging costs.


Subject(s)
Biopsy, Fine-Needle/methods , Endosonography/methods , Lung Neoplasms/pathology , Lung/pathology , Neoplasm Staging/methods , Adult , Aged , Aged, 80 and over , Female , Humans , Lung Neoplasms/diagnostic imaging , Lymphatic Metastasis/diagnostic imaging , Lymphatic Metastasis/pathology , Male , Middle Aged , Prospective Studies , Tomography, Emission-Computed , Ultrasonography, Interventional
8.
AJR Am J Roentgenol ; 180(1): 223-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12490509

ABSTRACT

OBJECTIVE: Three-dimensional data for noninvasive imaging of the coronary arteries are acquired from electron beam CT, multidetector CT, or MR imaging. Most commonly, surface rendering is used for three-dimensional processing, but recent advances in hardware and software technology have made it possible to use volume rendering. Our objective was to compare volume rendering with surface rendering for the visualization of the coronary artery tree. CONCLUSION: Our experience in the comparison of both techniques shows that because of intrinsic problems associated with surface rendering, volume rendering produces better image quality.


Subject(s)
Coronary Angiography , Image Processing, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Coronary Artery Disease/diagnostic imaging , Humans , Imaging, Three-Dimensional/methods , Stents
SELECTION OF CITATIONS
SEARCH DETAIL
...